Bliss GVS Pharma (BOM:506197) E10: ₹9.93 (As of Mar. 2026)


BOM:506197 Bliss GVS Pharma Ltd BOM:506197
57 GF Score
Price ₹509.15
GF Value ₹151.62
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Bliss GVS Pharma E10?

Bliss GVS Pharma BOM:506197 -0.47% 57 E10 is ₹9.93 as of Mar. 2026. GuruFocus rates BOM:506197 with a GF Score™ of 57/100 and a GF Value™ of ₹151.62 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Bliss GVS Pharma's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹3.270. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹9.93 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Bliss GVS Pharma's average E10 Growth Rate was 3.40% per year. During the past 3 years, the average E10 Growth Rate was 1.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Bliss GVS Pharma was 1.60% per year. The lowest was 1.20% per year. And the median was 1.40% per year.

As of today (2026-07-09), Bliss GVS Pharma's current stock price is ₹509.15. Bliss GVS Pharma's E10 for the quarter that ended in Mar. 2026 was ₹9.93. Bliss GVS Pharma's Shiller PE Ratio of today is 51.27.

During the past 13 years, the highest Shiller PE Ratio of Bliss GVS Pharma was 51.27. The lowest was 7.35. And the median was 12.29.


Bliss GVS Pharma  (BOM:506197) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Bliss GVS Pharma's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=509.15/9.93
=51.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Bliss GVS Pharma was 51.27. The lowest was 7.35. And the median was 12.29.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Bliss GVS Pharma E10 Related Terms


Bliss GVS Pharma E10 Historical Data

* Premium members only.

The historical data trend for Bliss GVS Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bliss GVS Pharma E10 Chart

Bliss GVS Pharma Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.26 9.47 9.30 9.60 9.93

Bliss GVS Pharma Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.60 9.83 9.89 9.82 9.93

BOM:506197 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bliss GVS Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bliss GVS Pharma Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bliss GVS Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Bliss GVS Pharma's Shiller PE Ratio falls into.


BOM:506197
57GF Score
Bliss GVS Pharma Ltd BOM:506197
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bliss GVS Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bliss GVS Pharma's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=3.27/164.2724*164.2724
=3.270

Current CPI (Mar. 2026) = 164.2724.

Bliss GVS Pharma Quarterly Data

per share eps CPI Adj_EPS
201606 2.670 105.961 4.139
201609 2.460 105.961 3.814
201612 2.020 105.196 3.154
201703 3.210 105.196 5.013
201706 2.050 107.109 3.144
201709 4.930 109.021 7.428
201712 1.740 109.404 2.613
201803 -1.390 109.786 -2.080
201806 1.760 111.317 2.597
201809 4.020 115.142 5.735
201812 2.500 115.142 3.567
201903 1.750 118.202 2.432
201906 3.280 120.880 4.457
201909 3.000 123.175 4.001
201912 2.300 126.235 2.993
202003 0.850 124.705 1.120
202006 1.540 127.000 1.992
202009 1.540 130.118 1.944
202012 2.430 130.889 3.050
202103 0.580 131.771 0.723
202106 2.290 134.084 2.806
202109 2.010 135.847 2.431
202112 -4.830 138.161 -5.743
202203 1.870 138.822 2.213
202206 2.440 142.347 2.816
202209 1.330 144.661 1.510
202212 2.640 145.763 2.975
202303 0.330 146.865 0.369
202306 1.380 150.280 1.508
202309 3.980 151.492 4.316
202312 2.600 152.924 2.793
202403 -0.880 153.035 -0.945
202406 1.930 155.789 2.035
202409 2.290 157.882 2.383
202412 2.270 158.323 2.355
202503 1.460 157.552 1.522
202506 4.040 159.755 4.154
202509 2.540 162.289 2.571
202512 2.140 163.281 2.153
202603 3.270 164.272 3.270

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹9.93 mean?
Bliss GVS Pharma (BOM:506197) has a E10 of ₹9.93 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bliss GVS Pharma and its competitors.
Is Bliss GVS Pharma's E10 too high?
Bliss GVS Pharma's current E10 is ₹9.93. Overall, Bliss GVS Pharma has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Bliss GVS Pharma's E10 compare to ZTS and UTHR?
Bliss GVS Pharma's E10 of ₹9.93 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Bliss GVS Pharma and its competitors. Bliss GVS Pharma's current E10 is ₹9.93. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bliss GVS Pharma stock overvalued right now?
Based on GuruFocus' analysis, Bliss GVS Pharma (BOM:506197) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹151.62, compared to a current price of ₹509.15 — trading 235.8% above its estimated fair value. The current E10 is ₹9.93. Bliss GVS Pharma's overall GF Score™ is 57/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Bliss GVS Pharma (BOM:506197), the current E10 is ₹9.93 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bliss GVS Pharma (BOM:506197) Overvalued in 2026?

Based on GuruFocus' analysis, Bliss GVS Pharma stock appears to be overvalued. The current stock price of ₹509.15 is trading 235.8% above its estimated GF Value™ of ₹151.62. GuruFocus considers Bliss GVS Pharma to be Significantly Overvalued.

Key valuation signals for BOM:506197:

  • E10: ₹9.93
  • GF Value™: ₹151.62 vs. price of ₹509.15 (235.8% above fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the BOM:506197 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bliss GVS Pharma Business Description

Other Exchanges BLISSGVS:India
Address Saki Vihar Road, 102, Hyde Park, Andheri (East), Mumbai, MH, IND, 400072
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.
57GF Score

Get the complete analysis for BOM:506197

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹509.15
Price
₹151.62
GF Value